A method for isolation and identification of urinary biomarkers in patients with diabetic nephropathy

Proteomics - Clinical Applications

Volumn 5, Issue 11-12, 2011, Pages 603-612

  Fisher, Wayne G ^a   Lucas, Jessica E ^a   Mehdi, Uzma F ^a   Qunibi, Danna W ^a   Garner, Harold R ^b   Rosenblatt, Kevin P ^c   Toto, Robert D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Diabetic nephropathy; Immunodepletion; LC; Proteomic methods; Urinary biomarkers

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA 1 BETA GLYCOPROTEIN; ALPHA 1 MICROGLOBULIN; ALPHA2 GLYCOPROTEIN; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; CD59 ANTIGEN; GLYCOPROTEIN; HAPTOGLOBIN; HEMOPEXIN; KININOGEN; OSTEOPONTIN; PREALBUMIN; PROTEIN; PROTEIN ITIH4; PROTEIN MAP19; PROTEOME; RETINOL BINDING PROTEIN 4; TRANSFERRIN; UNCLASSIFIED DRUG; UTEROGLOBIN; VITAMIN D BINDING PROTEIN; ZINC ALPHA2 GLYCOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN ISOLATION; PROTEIN URINE LEVEL; SIGNAL NOISE RATIO; ULTRAFILTRATION; URINALYSIS;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, REVERSE-PHASE; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEINS; ULTRAFILTRATION; URINALYSIS;

EID: 84855170772     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201000156     Document Type: Article

References (40)

1. Brenner, B. M., Brenner and Rector's The Kidney, 8th Edn., Saunders, Philadelphia 2007.
2. de Zeeuw, D., Remuzzi, G., Parving, H. H., Keane, W. F. et al., Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int. 2004, 65, 2309-2320.
3. Fliser, D., Novak, J., Thongboonkerd, V., Argilés, À. et al., Advances in urinary proteome analysis and biomarker discovery. J. Am. Soc. Nephrol. 2007, 18, 1057-1071.
4. Thongboonkerd, V., Recent progress in urinary proteomics. Proteomics Clin. Appl. 2007, 1, 780-791.
5. Mischak, H., Julian, B. A., Novak, J., High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine. Proteomics Clin. Appl. 2007, 1, 792-804.
6. Candiano, G., Santucci, L., Petretto, A., Bruschi, M. et al., 2D-electrophoresis and the urine proteome map: where do we stand? J. Proteomics 2010, 73, 829-844.
7. Pieper, R., Gatlin, C. L., McGrath, A. M., Makusky, A. J. et al., Characterization of the human urinary proteome: a method for high resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct spots. Proteomics 2004, 4, 1159-1174.
8. Ünlü, M., Morgan, M. E., Mindan, J. S., Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
9. Sharma, K., Lee, S., Han, S., Lee, S. et al., Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 2005, 5, 2648-2655.
10. Rao, P. V., Lu, X., Standley, M., Pattee, P. et al., Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007, 30, 629-637.
11. Kolch, W., Neusüß, C., Pelzing, M., Mischak, H., Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom. Rev. 2005, 24, 959-977.
12. Metzger, J., Schanstra, J., Mischak, H., Capillary electrophoresis-mass spectrometry in urine proteome analysis: current applications and future developments. Anal. Bioanal. Chem. 2009, 393, 1431-1442.
13. Zhang, X., Fang, A., Riley, C. P., Wang, M. et al., Multi-dimensional liquid chromatography in proteomics - a review. Anal. Chim. Acta 2010, 664, 101-113.
14. Chong, B. E., Yan, F., Lubman, D. M., Miller, F. R., Chromatofocusing non-porous reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of proteins from human breast cancer whole cell lysates: a novel two-dimensional liquid chromatography/mass spectrometry method. Rapid Commun. Mass Spectrom. 2001, 15, 291-296.
15. Soldi, M., Sarto, C., Valsecchi, C., Magni, F. et al., Proteome profile of human urine with two-dimensional liquid phase fractionation. Proteomics 2005, 5, 2641-2647.
16. Linke, T., Ross, A. C., Harrison, E. H., Proteomic analysis of rat plasma by two-dimensional liquid chromatography and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J. Chromatogr. A 2006, 1123, 160-169.
17. Martosella, J., Zolotarjova, N., Liu, H., Nicol, G., Boyes, B. E., Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. J. Proteome Res. 2005, 4, 1522-1537.
18. Zolotarjova, N., Mrozinski, P., Chen, H., Martosella, J., Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum. J. Chromatogr. A 2008, 1189, 332-338.
19. Linke, T., Doraiswamy, S., Harrison, E. H., Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 849, 273-281.
20. Chen, Y.-T., Tsao, C.-Y., Li, J.-M., Tsai, C.-Y. et al., Large-scale protein identification of human urine proteome by multi-dimensional LC and MS/MS. Proteomics Clin. Appl. 2007, 1, 577-587.
21. Mehdi, U. F., Adams-Huet, B., Raskin, P., Vega, G. L., Toto, R.D., Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J. Am. Soc. Nephrol. 2009, 20, 2641-2650.
22. Pappin, D. J. C., Hojrup, P., Bleasby, A. J., Rapid identification of proteins by peptide-mass fingerprinting. Curr. Biol. 1993, 3, 327-332.
23. Lowenthal, M. S., Mehta, A. I., Frogale, K., Bandle, R. W. et al., Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin. Chem. 2005, 51, 1933-1945.
24. Brand, J., Haslberger, T., Zolg, W., Pestlin, G., Palme, S., Depletion efficiency and recovery of trace markers from a mutiparameter immunodepletion column. Proteomics 2006, 6, 3236-3242.
25. Tyan, Y.-C., Guo, H.-R., Liu, C.-Y., Liao, P.-C., Proteomic profiling of human urinary proteome using nano-high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal. Chim. Acta 2006, 570, 158-176.
26. Kanai, M., Raz, A., Goodman, D. S., Retinol binding protein: the transport protein for Vitamin A in human plasma. J. Clin. Invest. 1968, 47, 2025-2044.
27. Naylor, H. M., Newcomer, M. E., The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry 1999, 38, 2647-2653.
28. Candiano, G., Bruschi, M., Petretto, A., Santucci, L. et al., Proteins and protein fragments in nephrotic syndrome: clusters, specificity and mechanisms. Proteomics Clin. Appl. 2008, 2, 956-963.
29. Mukherjee, A. B., Kundu, G. C., Mandal, A. K., Pattabiraman, N. et al., Uteroglobin: physiological role in normal glomerular function uncovered by targeted disruption of the uteroglobin gene in mice. Am. J. Kidney Dis. 1998, 32, 1106-1120.
30. Weston, B. S., Wahab, N. A., Mason, R. M., CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells. J. Am. Soc. Nephrol. 2003, 14, 601-610.
31. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., Mann, M., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
32. Castagna, A., Cecconi, D., Sennels, L., Rappsilber, J. et al., Exploring the hidden human urinary proteome via ligand library beads. J. Proteome Res. 2005, 4, 1917-1930.
33. Rocchetti, M. T., Centra, M., Papale, M., Bortone, G. et al., Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Proteomics 2008, 8, 206-216.
34. Woroniecki, R. P., Orlova, T. N., Mendelev, N., Shata, I. F. et al., Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood. Am. J. Nephrol. 2006, 26, 258-267.
35. Khurana, M., Traum, A. Z., Aivado, M., Wells, M. P. et al., Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr. Nephrol. 2006, 21, 1257-1265.
36. Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T. et al., Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 2001, 345, 851-860.
37. Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F. et al., Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 2001, 345, 861-869.
38. Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R. et al., The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 2001, 345, 870-878.
39. Ravid, M., Savin, H., Jutrin, I., Bental, T., Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in type II diabetic patients. Ann. Intern. Med. 1993, 118, 577-581.
40. Chan, J. C. N., Ko, G. T. C., Leung, D. H. Y., Cheung, R. C. K. et al., Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. Kidney Int. 2000, 57, 590-600.